Multi-Organ Protective Effects of Sodium Glucose Cotransporter 2 Inhibitors


eMediNexus    14 May 2022

SGLT2is block the reabsorption of glucose by inhibiting the sodium glucose cotransporter 2 receptor. Hence, these agents improve glucose metabolism by promoting renal excretion of glucose irrespective of insulin secretion.

The advantages of SGLT2is in diabetes include – reduction in body weight; improvement in insulin resistance; glucose homeostasis; and prevention of organ damage. Recent evidence suggests that SGLT2i protects against cardiovascular death, development of HF, as well as the progression of kidney disease. Additionally, SGLT2i effectively lowers the liver fat content and reverses hepatic fibrosis. 

Thus, these drugs confer improvements in multiple organs and provide protection against cardiovascular, renal, and hepatic damage. Their mechanisms underlying organ protection, besides glucose-lowering effects include – improvement of insulin resistance for anti-atherogenesis, osmotic diuresis for cardiac protection, fatty acids utilization for hepatic protection, and improvement of tubuloglomerular feedback for renal protection.

Source: International Journal of Molecular sciences. 2021 Apr 23;22(9):4416.doi: 10.3390/ijms22094416.

To comment on this article,
create a free account.

Sign Up to instantly get access to 10000+ Articles & 1000+ Cases

Already registered?

Login Now

Most Popular Articles

News and Updates

eMediNexus provides latest updates on medical news, medical case studies from India. In-depth medical case studies and research designed for doctors and healthcare professionals.